Medtronic's purchase of Synectics will provide urologic, GI, neurologic, diagnostic systems.

MEDTRONIC TO GET DIAGNOSTICS FOR UROLOGIC, GI, NEUROLOGIC, SLEEP DISORDERS through the proposed acquisition of the shares of Synectics Medical AB that Medtronic does not already own. Medtronic announced a tender offer March 11 to acquire the remaining shares of the Stockholm, Sweden-based company for approximately $41.74 per share, or about $59 mil. Synectics recently has been trading in the $34 range on the Stockholm Stock Exchange, according to Medtronic.